Diabetes and the role of isoprenoid biosynthesis

被引：9

作者：

Bliznakov, EG ^{[1
]}

机构：

[1] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-100133 Rome, Italy

来源：

FEBS LETTERS | 2002年 / 525卷 / 1-3期

关键词：

D O I：

10.1016/S0014-5793(02)03062-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：169 / 170

页数：2

共 13 条

[1] Lipid-lowering drugs (statins), cholesterol, and coenzyme Q(10). The Baycol case - a modern Pandora's box [J].

Bliznakov, EG .

BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (01) :56-59

[2]

Bliznakov EG, 1998, ADV THER, V15, P218

[3] Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes [J].

Chamberlain, LH .

FEBS LETTERS, 2001, 507 (03) :357-361

[4] Beneficial effects of α-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients:: Relation to parameters of oxidative stress [J].

Heitzer, T ;

Finckh, B ;

Albers, S ;

Krohn, K ;

Kohlschüter, A ;

Meinertz, T .

FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (01) :53-61

[5]

KISHI T, 1976, J MED, V7, P307

[6] Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion. [J].

Langin, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (24) :1772-1774

[7] Can correction of sub-optimal coenzyme Q status improve β-cell function in type II diabetics? [J].

McCarty, MF .

MEDICAL HYPOTHESES, 1999, 52 (05) :397-400

[8] Lipid peroxidation and atherosclerosis in type II diabetes [J].

Oranje, WA ;

Wolffenbuttel, BHR .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (01) :19-32

[9]

SINATRA ST, 1998, COENZYME Q10 PHENOME, P99

[10] Effect of hydrosoluble coenzyme Q10 on blood pressures and Insulin resistance in hypertensive patients with coronary artery disease [J].

Singh, RB ;

Niaz, MA ;

Rastogi, SS ;

Shukla, PK ;

Thakur, AS .

JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (03) :203-208

← 1 2 →